Imidazo-substituted compounds as p38 kinase inhibitors

Details Imidazo-substituted compounds as p38 kinase inhibitors Imidazo-substituted compounds as p38 kinase inhibitors

2005-09-27

2005-09-27

Balasubramanian, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S251000

Reexamination Certificate

active

06949560

ABSTRACT:
The present invention discloses compounds corresponding to formula I:wherein A, Z, Z1, Y, R1and R2are as defined in the specification, as well as pharmaceutical formulations, methods of making and uses thereof.

REFERENCES:
patent: 4522947 (1985-06-01), Musser et al.
patent: 4650737 (1987-03-01), Wiedemann
patent: 4656281 (1987-04-01), Musser et al.
patent: 4831040 (1989-05-01), Decktor et al.
patent: 0542497 (1993-05-01), None
patent: 11-292878 (1998-04-01), None
patent: WO 02/064594 (2002-08-01), None
Wolft Manfred E. “Burger's Medicinal Chemistry, 5ed, Part 1”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al., “Modern Pharmaceutices, 3ed.”, Marcel Dekker, New York. 1996, pp. 451 and 596.
Brunet et al., Esaays Biochem. 32: 1-16, 1997.
Nagarkatti et al., J. Mol. Cell. Cardiol. 30(8): 1651-1664, 1998.
Herlaar et al., Mol. Med. Today 5(10) 439-447, 1999.
Graninger et al., Currr. Opin. Rheumatol. 13(30: 209-13, 2001.

Affiliated with

Also associated with

Rating

Imidazo-substituted compounds as p38 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazo-substituted compounds as p38 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo-substituted compounds as p38 kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3444131